US OptionsDetailed Quotes
USNA241220P55000
- 0.00
- 0.000.00%
15min DelayClose Nov 29 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest55.00Strike Price0.00Turnover0.00%IV-42.75%PremiumDec 20, 2024Expiry Date16.47Intrinsic Value100Multiplier21DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.34Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Usana Health Sciences Stock Discussion
Sign in to post a comment
Multiple insiders at USANA Health Sciences selling shares over the past year may worry investors. However, high insider ownership could suggest the company operates in all shareholders' interest. The absence of insider buying in the last three months, along with some selling, does not inspire confidence.
1
Despite similar P/E ratios to the market, the company's declining earnings spark hope for a business turnaround among investors. However, analysts express doubt and fear that these declining earnings could negatively impact the share price.
Despite challenges, personal care stocks sector showed resilience with average share prices up 20.3%. Nature's Sunshine and Olaplex outperformed, while Nu Skin, USANA, and BeautyHealth underperformed.
1
USANA Health Sciences's share price is stable and undervalued. Despite muted growth, it may be a good time to accumulate more holdings. The company's future outlook isn't reflected in the current price, suggesting USNA stocks are still a good buy.
1
Caution suggested due to significant insider selling at USANA Health Sciences over the past year. Despite high insider ownership, lack of recent purchases coupled with history of sales indicates potentially cautious sentiment.
Gainers:
In reaction to earnings/guidance:
• $Teva Pharmaceutical Industries (TEVA.US)$ +24%(also announces agreement for opioids settlement), $Enphase Energy (ENPH.US)$ +9.5%, $Spotify Technology (SPOT.US)$ +9.2%, $RPC Inc (RES.US)$ +8.5%, $Chipotle Mexican Grill (CMG.US)$ +8.2%, $Manhattan Associates (MANH.US)$ +8.1%, $Hilton Worldwide (HLT.US)$ +6.7%, $ChampionX (CHX.US)$ +6.1%, $Mr. Cooper Group (COOP.US)$ +5.7%, $Constellium (CSTM.US)$ +5.5%, $Boston Scientific (BSX.US)$ +5.4%, ...
In reaction to earnings/guidance:
• $Teva Pharmaceutical Industries (TEVA.US)$ +24%(also announces agreement for opioids settlement), $Enphase Energy (ENPH.US)$ +9.5%, $Spotify Technology (SPOT.US)$ +9.2%, $RPC Inc (RES.US)$ +8.5%, $Chipotle Mexican Grill (CMG.US)$ +8.2%, $Manhattan Associates (MANH.US)$ +8.1%, $Hilton Worldwide (HLT.US)$ +6.7%, $ChampionX (CHX.US)$ +6.1%, $Mr. Cooper Group (COOP.US)$ +5.7%, $Constellium (CSTM.US)$ +5.5%, $Boston Scientific (BSX.US)$ +5.4%, ...
11
Gainers:
• $Veru Inc (VERU.US)$ +11.4% (extends momentum from +13% move during regular session)
• $Annovis Bio (ANVS.US)$ +9.4% (received notice from the FDA that the Phase 3 clinical study in early Parkinson's patients may proceed)
• $GameStop (GME.US)$ +6.7% (announces 4-for-l stock split)
• $Bed Bath & Beyond Inc (BBBY.US)$ +6% (interim CEO purchases 50000 shares)
• $VAALCO Energy (EGY.US)$ +5.4% (completes South Tchibala 1HB-ST W...
• $Veru Inc (VERU.US)$ +11.4% (extends momentum from +13% move during regular session)
• $Annovis Bio (ANVS.US)$ +9.4% (received notice from the FDA that the Phase 3 clinical study in early Parkinson's patients may proceed)
• $GameStop (GME.US)$ +6.7% (announces 4-for-l stock split)
• $Bed Bath & Beyond Inc (BBBY.US)$ +6% (interim CEO purchases 50000 shares)
• $VAALCO Energy (EGY.US)$ +5.4% (completes South Tchibala 1HB-ST W...
16
Upgrades
• $CDW Corp (CDW.US)$: Stifel Upgrades to Buy from Hold - PT $210 (from $200)
• $Corteva (CTVA.US)$ : Loop Capital Upgrades to Buy from Hold - PT $69
• $CoreCivic, Inc. (CXW.US)$ : Wedbush Upgrades to Outperform from Neutral - PT $17 (from $10.85)
• $Delta Air Lines (DAL.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $60 (from $42)
• $H.B. Fuller (FUL.US)$ : Baird Upgrades to Outperform from Neutral - PT $85
• $Huntington Ingalls Industries (HII.US)$ : Cowen U...
• $CDW Corp (CDW.US)$: Stifel Upgrades to Buy from Hold - PT $210 (from $200)
• $Corteva (CTVA.US)$ : Loop Capital Upgrades to Buy from Hold - PT $69
• $CoreCivic, Inc. (CXW.US)$ : Wedbush Upgrades to Outperform from Neutral - PT $17 (from $10.85)
• $Delta Air Lines (DAL.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $60 (from $42)
• $H.B. Fuller (FUL.US)$ : Baird Upgrades to Outperform from Neutral - PT $85
• $Huntington Ingalls Industries (HII.US)$ : Cowen U...
19
$Usana Health Sciences (USNA.US)$
Continue to expand its product line and global markets, leveraging its partnerships with global athletes, new technology and social media to grow its distributor and customer base. Yusana recently launched a new product recommendation tool and announced its Active Nutrition product line in March, enabling customers to build personalized recommended product lists to meet specific nutritional needs and fitness goals.
Continue to expand its product line and global markets, leveraging its partnerships with global athletes, new technology and social media to grow its distributor and customer base. Yusana recently launched a new product recommendation tool and announced its Active Nutrition product line in March, enabling customers to build personalized recommended product lists to meet specific nutritional needs and fitness goals.
8
$Usana Health Sciences (USNA.US)$ why the sudden drop?
1
No comment yet
102869948coco : Why is it falling every day lately